89bio, Inc.·4

Feb 19, 4:01 PM ET

Le-Nguyen Quoc 4

4 · 89bio, Inc. · Filed Feb 19, 2025

Insider Transaction Report

Form 4
Period: 2024-04-02
Le-Nguyen Quoc
See Remarks
Transactions
  • Award

    Common Stock

    2025-02-01$9.60/sh+8,750$84,00014,750 total(indirect: By Spouse)
  • Award

    Common Stock

    2024-12-12+6,0006,000 total(indirect: By Spouse)
  • Tax Payment

    Common Stock

    2025-02-17$10.57/sh1,050$11,099343,652 total
  • Award

    Stock Option (Right to Buy)

    2024-04-02+26,40026,400 total(indirect: By Spouse)
    Exercise: $10.58Exp: 2034-04-02Common Stock (26,400 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-02-01+17,50017,500 total(indirect: By Spouse)
    Exercise: $9.60Exp: 2035-02-01Common Stock (17,500 underlying)
Footnotes (5)
  • [F1]Represents restricted stock units that vest in equal semi-annual installments over two years, subject to the recipient's continued service to the Issuer.
  • [F2]Represents restricted stock units that vest in equal semi-annual installments over three years, subject to the recipient's continued service to the Issuer.
  • [F3]These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
  • [F4]Represents a right to purchase a total of 26,400 shares of the Issuer's Common Stock, one quarter of which will vest on April 2, 2025, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the recipient's continued service to the Issuer.
  • [F5]Represents a right to purchase a total of 17,500 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2026, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the recipient's continued service to the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4